Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
C1QL3 Biologics Sequence Review Report 2026: Complement C1q-like protein 3 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of C1QL3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
C1QB Biologics Sequence Review Report 2026: Complement C1q subcomponent subunit B Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of C1QB protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
C1QC Biologics Sequence Review Report 2026: Complement C1q subcomponent subunit C Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of C1QC protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
BRS3 Biologics Sequence Review Report 2026: Bombesin receptor subtype-3 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of BRS3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
C1QA Biologics Sequence Review Report 2026: Complement C1q subcomponent subunit A Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of C1QA protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
BUB3 Biologics Sequence Review Report 2026: Mitotic checkpoint protein BUB3 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of BUB3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
BST2 Biologics Sequence Review Report 2026: Bone marrow stromal antigen 2 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of BST2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
BCAP31 Biologics Sequence Review Report 2026: B-cell receptor-associated protein 31 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of BCAP31 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
BIVM Biologics Sequence Review Report 2026: Basic immunoglobulin-like variable motif-containing protein Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of BIVM protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
BDKRB2 Biologics Sequence Review Report 2026: B2 bradykinin receptor Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of BDKRB2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
BDKRB1 Biologics Sequence Review Report 2026: B1 bradykinin receptor Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of BDKRB1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
AVPR2 Biologics Sequence Review Report 2026: Vasopressin V2 receptor Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of AVPR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
19
20
21
22
23
>>
1586
>